Champions Oncology, Inc. (CSBR)
4.94
+0.06
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
5.17
+0.23
(+4.66%)
Pre-Market: 20:00
Champions Oncology Price to Book Value : 17.66 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 17.66 |
| October 01, 2026 | 17.45 |
| September 30, 2026 | 17.88 |
| September 29, 2026 | 17.13 |
| September 28, 2026 | 17.63 |
| September 25, 2026 | 17.52 |
| September 24, 2026 | 17.70 |
| September 23, 2026 | 17.95 |
| September 22, 2026 | 18.91 |
| September 21, 2026 | 18.81 |
| September 18, 2026 | 18.95 |
| September 17, 2026 | 18.16 |
| September 16, 2026 | 17.70 |
| September 15, 2026 | 17.05 |
| September 14, 2026 | 17.59 |
| September 11, 2026 | 18.23 |
| September 10, 2026 | 18.22 |
| September 09, 2026 | 17.91 |
| September 08, 2026 | 18.06 |
| September 04, 2026 | 18.66 |
| September 03, 2026 | 18.88 |
| September 02, 2026 | 18.41 |
| September 01, 2026 | 17.88 |
| August 31, 2026 | 17.86 |
| August 28, 2026 | 17.63 |
| Date | Value |
|---|---|
| August 27, 2026 | 17.95 |
| August 26, 2026 | 17.59 |
| August 25, 2026 | 17.80 |
| August 24, 2026 | 17.77 |
| August 21, 2026 | 17.73 |
| August 20, 2026 | 18.52 |
| August 19, 2026 | 17.66 |
| August 18, 2026 | 18.20 |
| August 17, 2026 | 17.98 |
| August 14, 2026 | 18.11 |
| August 13, 2026 | 18.16 |
| August 12, 2026 | 17.70 |
| August 11, 2026 | 17.84 |
| August 10, 2026 | 18.38 |
| August 07, 2026 | 18.56 |
| August 06, 2026 | 18.56 |
| August 05, 2026 | 18.95 |
| August 04, 2026 | 19.49 |
| August 03, 2026 | 20.59 |
| July 31, 2026 | 19.16 |
| July 30, 2026 | 18.54 |
| July 29, 2026 | 19.25 |
| July 28, 2026 | 19.50 |
| July 27, 2026 | 21.36 |
| July 24, 2026 | 21.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Medpace Holdings, Inc. | 38.47 |
| Avantor, Inc. | 1.843 |
| Personalis, Inc. | 7.364 |
| Adaptive Biotechnologies Corp. | 31.55 |
| 10X Genomics, Inc. | 14.76 |
Price to Book Value Related Metrics
| PS Ratio | 1.143 |
| Price | 4.94 |
| Earnings Yield | -1.62% |
| Market Cap | 68.76M |